• Home
  • Medical & Pharmacy Policy Update

Medical & Pharmacy Policy Update

Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on our website.

Published 12/01/23:

  • Carrier Screening for Genetic Diseases
  • Vyjuvek
  • Bevacizumab

To view these medical policies, please visit our Medical Policy page of our website, https://www.bcbsks.com/providers/medical-policies.

The following Pharmacy Medical Policy programs will be updated January 1, 2024:

  • GLP-1 Agonists
  • Colony Stimulating Factors
  • Injectable and Health Care Administered Oncology
  • Constipation Agents
  • Oral PAH
  • Antidepressant
  • CMV
  • Winlevi
  • Efgartigimod
  • Relyvrio
  • Oral Inhalers
  • Pancreatic Enzyme
  • Vyjuvek
  • Bevacizumab

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website,  https://www.bcbsks.com/providers/precertification-prior-authorization.

If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.

Institutional Providers
Professional Providers